Sichuan Hebang Biotechnology Co Ltd Total Liabilities
Sichuan Hebang Biotechnology Co Ltd total liabilities. Based on the latest financial reports, Sichuan Hebang Biotechnology Co Ltd (603077) has total liabilities worth CN¥10.30 Billion CNY (≈ $1.51 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sichuan Hebang Biotechnology Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Total liabilities of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025. This chart illustrates how Sichuan Hebang Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 603077 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Sichuan Hebang Biotechnology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Sichuan Hebang Biotechnology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TGS NOPEC Geophysical Company ASA
OL:TGS
|
Norway | Nkr1.91 Billion |
|
Hang Zhou Iron & Steel Co Ltd
SHG:600126
|
China | CN¥13.92 Billion |
|
Shanxi Securities Co Ltd
SHE:002500
|
China | CN¥71.93 Billion |
|
Guangdong Create Century Intelligent Equipment Group Corp Ltd
SHE:300083
|
China | CN¥6.95 Billion |
|
NovaGold Resources Inc
TO:NG
|
Canada | CA$168.27 Million |
|
Fattal 1998 Holdings Ltd
TA:FTAL
|
Israel | ILA24.31 Billion |
|
Shenzhen Woer Heat-Shrinkable Material Co Ltd
SHE:002130
|
China | CN¥6.09 Billion |
|
Ahlatci Dogal Gaz Dagitim Enerji ve Yatirim A.S.
IS:AHGAZ
|
Turkey | TL163.86 Billion |
Liability Composition Analysis (2009–2025)
This chart breaks down Sichuan Hebang Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Sichuan Hebang Biotechnology Co Ltd.
Liquidity & Leverage Metrics
Sichuan Hebang Biotechnology Co Ltd Total Liabilities Ratios Explained
Sichuan Hebang Biotechnology Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sichuan Hebang Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sichuan Hebang Biotechnology Co Ltd (2009–2025)
The table below shows the annual total liabilities of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥10.25 Billion ≈ $1.50 Billion |
-3.69% |
| 2024-12-31 | CN¥10.64 Billion ≈ $1.56 Billion |
+146.14% |
| 2023-12-31 | CN¥4.32 Billion ≈ $632.74 Million |
-0.35% |
| 2022-12-31 | CN¥4.34 Billion ≈ $634.99 Million |
+32.09% |
| 2021-12-31 | CN¥3.29 Billion ≈ $480.71 Million |
-4.30% |
| 2020-12-31 | CN¥3.43 Billion ≈ $502.29 Million |
+13.25% |
| 2019-12-31 | CN¥3.03 Billion ≈ $443.54 Million |
+45.14% |
| 2018-12-31 | CN¥2.09 Billion ≈ $305.59 Million |
+13.88% |
| 2017-12-31 | CN¥1.83 Billion ≈ $268.35 Million |
-14.78% |
| 2016-12-31 | CN¥2.15 Billion ≈ $314.88 Million |
-53.37% |
| 2015-12-31 | CN¥4.62 Billion ≈ $675.33 Million |
+5.36% |
| 2014-12-31 | CN¥4.38 Billion ≈ $640.95 Million |
+91.08% |
| 2013-12-31 | CN¥2.29 Billion ≈ $335.43 Million |
+39.63% |
| 2012-12-31 | CN¥1.64 Billion ≈ $240.24 Million |
-29.88% |
| 2011-12-31 | CN¥2.34 Billion ≈ $342.61 Million |
+9.19% |
| 2010-12-31 | CN¥2.14 Billion ≈ $313.76 Million |
-11.74% |
| 2009-12-31 | CN¥2.43 Billion ≈ $355.51 Million |
-- |
About Sichuan Hebang Biotechnology Co Ltd
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, ultra-high efficiency silic… Read more